SIASUN(SZ:300024) Jin Rong Jie·2025-12-04 08:36Market Overview - The Hong Kong stock market showed a positive trend with the Hang Seng Index rising by 0.68% to close at 25,935.9 points, while the Hang Seng Tech Index increased by 1.45% to 5,615.43 points [1] - Major technology stocks experienced gains, with Xiaomi Group up by 4.38% and Meituan up by 2.29% [1] - The innovative drug sector led the market, with companies like Genscript Biotech rising over 11% [1] - Semiconductor stocks also performed well, with SMIC and Hua Hong Semiconductor both increasing by over 3% [1] Company News - InnoCare Pharma (02577.HK) announced a strategic cooperation agreement with ON Semiconductor to accelerate the GaN industry ecosystem, potentially generating hundreds of millions in GaN sales in the coming years [2] - Aoyuan Group (03383.HK) reported a pre-sale amount of approximately 8.08 billion yuan for the first 11 months, a decrease of 45.2% year-on-year [3] - Jingrui Holdings (01862.HK) reported a cumulative contract sales amount of approximately 876 million yuan for the first 11 months, down 54.1% year-on-year [4] - China Aluminum International (02068.HK) announced that its subsidiary won a bid for a new electrolytic aluminum project with a total contract value of 3.03 billion yuan [4] - Stone Pharmaceutical Group (01093.HK) received clinical trial approval for a selective 5-HT2A receptor agonist in the U.S. [5] - Fosun Pharma (02196.HK) announced that its subsidiary's FXS887 tablet received clinical trial approval [6] - Zai Lab (02617) and Eucure Biopharma (06996) received regulatory approvals for their respective drugs in China [7] Institutional Insights - Guotai Junan Securities indicated that the short-term adjustment in the Hong Kong market opens up space for a rise in 2026, with over 110 billion yuan of net inflow from southbound funds in November [9] - Huaxia Fund noted that the technology sector in Hong Kong has been oversold due to irrational panic, and the outlook for AI development is pragmatic, suggesting a left-side layout strategy [9] - JPMorgan Chase projected a higher risk of significant increases in the Chinese stock market by 2026, with a 19% upside potential for the MSCI China Index [9] - Invesco expressed optimism about the long-term outlook for Hong Kong and A-shares, highlighting attractive valuations and the influx of mainland tech companies going public in Hong Kong [10]